Trade Gulf Pharmaceutical Industries PSC - JULPHAR
Gulf Pharmaceutical Industries PSC (ADX: JULPHAR) is one of the Middle East’s leading pharmaceutical manufacturers, dedicated to producing high-quality medicines across multiple therapeutic areas. With a strong presence in regional and global markets, the company plays a critical role in enhancing healthcare accessibility. By investing in research, innovation, and state-of-the-art manufacturing facilities, Gulf Pharmaceutical Industries ensures the development of cutting-edge pharmaceutical solutions. Its commitment to quality and regulatory excellence positions it as a trusted healthcare provider. As the demand for innovative and affordable healthcare solutions rises, Gulf Pharmaceutical Industries continues to expand its product portfolio, supporting medical advancements and public health initiatives.Latest shares articles

US midterms: the end of uncertainty could give Wall Street direction
Markets dislike uncertainty and volatility tends to rise ahead of the vote, but once the results are known, indices may be able to set a clearer direction.
13:28, 29 October 2026

BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026

TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026

Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026